07 September 2022
This week the BioMedTech Horizons (BMTH) team is in Perth meeting with awardees prior to the WA BMTH Showcase event on Friday 9 September. The Showcase will feature an opening address from the Hon. Stephen Dawson MLC, WA’s Minister for Innovation, ICT and Medical Research and will celebrate some of WA’s outstanding medtech organisations and projects.
Delivered by MTPConnect, the Australian Government's $45 million BMTH is a Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept, and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
Across four funding rounds, the BMTH program has funded 49 projects. Investments are focused on supporting proof-of-concept to commercial development of biomedical and medical technologies.
Opportunity to hear from WA-based companies awarded BMTH funding
The WA BMTH Showcase provides an opportunity to hear from WA-based companies awarded BMTH funding to develop and commercialise their medtech innovations, as they showcase their successes, commercialisation journey and future plans to WA’s Minister for Innovation, ICT and Medical Research.
The event will be delivered by the MTPConnect WA Life Sciences Innovation Hub, which was co-founded through the WA Government’s New Industries Fund and the University of Western Australia to accelerate economic growth and create new jobs and industries.
Located at The University of Western Australia (UWA) at the Harry Perkins Institute of Medical Research Building, Nedlands, the team delivers a program of activities to provide opportunities for the WA MTP sector.
It is one of the three WA Government Innovation Hubs that deliver programs to connect the innovation community, build capacity and new skills, attract investment, and foster commercialisation.
In-person BMTH project progress updates
This week, the BMTH team is meeting in-person with awardees in WA for project progress updates, with the week culminating in the WA BMTH Showcase at The Harry Perkins Institute of Medical Research Building at The University of Western Australia.
BMTH projects based in WA are:
- Advanced Genetic Diagnostics – developing a range of tests to accurately predict the risk of several heart disease conditions based only on a person’s genetic variants.
- Artrya – using Artificial Intelligence to develop a non-invasive, cost-effective tool which evaluates Cardiac CT Angiography and assesses areas of restricted blood flow in the heart within minutes
- Cortical Dynamics – developed the Brain Anaesthesia Response Monitor (BARMTM) with the objective of better detecting the effect of anaesthetic agents on brain activity and is implementing a rich brain data lake using its Enigma platform
- Ear Science Institute Australia – developed ClearDrum is an acoustically optimised silk fibroin membrane for the treatment of chronic middle ear disease, which is heading towards first-in-human trials
- OncoRes Medical – developed compact wireless technology for improved accuracy during breast conserving surgery
- Proteomics International – further developing its patented PromarkerD test which predicts the onset of Diabetic Kidney Disease and establishing onshore manufacturing
- VitalTrace – developing a precision real-time fetal biosensor for the prevention of stillbirth and fetal complications during childbirth.
Our WA Life Sciences Innovation Hub invites you to join the BMTH Showcase event on Friday to hear more about the insights, successes, and development and commercialisation stories from innovative WA companies.